CLINICAL_TRIALS
trial_result
· 2016-06-06
Clinical Trial Update: A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients [Phase 1]
Summary
Phase I trial of ALECSAT in glioblastoma multiforme patients has completed, assessing tolerability and preliminary efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CytoVac A/S | Conditions: Glioblastoma Multiforme | Phase 1 | Status: COMPLETED